Pharmacologic Therapies in Anticoagulation.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 27235611.
- Also identified by DOI 10.1016/j.mcna.2016.03.007.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Anticoagulants are beneficial for prevention and treatment of venous thromboembolism and stroke prevention in atrial fibrillation. The development of target-specific oral anticoagulants is changing the landscape of anticoagulation therapy and created growing interest on this subject. Understanding the pharmacology of different anticoagulants is the first step to adequately treat patients with best available therapy while avoiding serious bleeding complications. This article reviews the pharmacology of the main anticoagulant classes (vitamin K antagonists, direct oral anticoagulants, and heparins) and their clinical indications based on evidence-based data currently available in the literature.
Medical subject headings
- Anticoagulants
- Atrial Fibrillation
- Stroke
- Venous Thromboembolism